In a report released on June 9, Davide Longo from TP ICAP MIDCAP maintained a Buy rating on GPI SpA (GPI – Research Report), with a price target of €20.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Davide Longo has given his Buy rating due to a combination of factors that highlight GPI SpA’s strategic advancements and financial positioning. The recent €2.1 million contract with Corofar Distribuzione is a testament to GPI’s growing influence in the pharmaceutical logistics sector. This contract, while not significantly altering the company’s financials, enhances the RIEDL brand’s presence in the wholesale segment, potentially paving the way for similar deals across national and European markets.
Additionally, the successful placement of the €41.5 million senior unsecured bond “Bullet 2031” further strengthens GPI’s financial flexibility. This bond issuance not only consolidates the company’s financial structure but also provides the necessary capital for organic growth and potential acquisitions in the healthcare IT and services sectors. These strategic moves, coupled with the company’s robust market position, underpin Longo’s confidence in recommending a Buy rating for GPI SpA.